ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,313.40
-0.05%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,343.785
-0.35%
Brent Oil
82.805
-0.05%
Bitcoin
67,775.08
-2.33%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Maia Biotechnology Inc (MAIA)

  7. Maia Biotechnology Inc (MAIA) News

Maia Biotechnology (MAIA)

Maia Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:MAIA
DateTimeSourceHeadlineSymbolCompany
17/05/202413:37Business WireMAIA Biotechnology to Present at the BIO International Convention 2024AMEX:MAIAMaia Biotechnology Inc
16/05/202413:37Business WireMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingAMEX:MAIAMaia Biotechnology Inc
15/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
15/05/202421:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:MAIAMaia Biotechnology Inc
14/05/202421:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:MAIAMaia Biotechnology Inc
07/05/202422:21Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
30/04/202413:08Business WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
29/04/202413:08Business WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementAMEX:MAIAMaia Biotechnology Inc
23/04/202413:51Business WireMAIA Biotechnology Announces $1.00 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
05/04/202413:01Business WireMAIA Biotechnology to Present at Two Investor Conferences in April 2024AMEX:MAIAMaia Biotechnology Inc
28/03/202419:00Business WireMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroAMEX:MAIAMaia Biotechnology Inc
26/03/202419:00Business WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
26/03/202412:01Business WireMAIA Biotechnology Announces $1.33 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
22/03/202419:00Business WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
21/03/202419:00Business WireMAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory BoardAMEX:MAIAMaia Biotechnology Inc
08/03/202421:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
07/03/202414:45Business WireMAIA Biotechnology to Participate in the 36th Annual ROTH ConferenceAMEX:MAIAMaia Biotechnology Inc
06/03/202416:04Business WireMAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual MeetingAMEX:MAIAMaia Biotechnology Inc
06/03/202413:48Business WireMAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer PatientsAMEX:MAIAMaia Biotechnology Inc
06/03/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/03/202413:45Business WireMAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to ShareholdersAMEX:MAIAMaia Biotechnology Inc
27/02/202422:23Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
23/02/202421:17Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
14/02/202422:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:MAIAMaia Biotechnology Inc
14/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
07/02/202413:01Business WireMAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
30/01/202414:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
26/01/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:MAIAMaia Biotechnology Inc
26/01/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:MAIAMaia Biotechnology Inc
26/01/202421:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:MAIAMaia Biotechnology Inc
 Showing the most relevant articles for your search:AMEX:MAIA

Your Recent History

BIT
UB2Y5H
UniCredit Bank
TSX
COMM
BMO Global Communication...
LSE
FINW
Am World Finusd
NYSE
CNI
Canadian National Railway
LSE
UMB
Umbro
BOV
M1LC34R
Melco Resorts & Entertai...
LSE
GKP
Gulf Keystone Petroleum
NYSE
ABA
BMF
DITN26
DITN26 - 07/2026
NASDAQ
GEHC
GE HealthCare Technologies
BIT
UB60NE
Unicredit Bank
LSE
SN.
Smith & Nephew
EU
FR001400N327
Credit Agricole Home Loa...
NYSE
MCD
McDonalds
NASDAQ
HFAJX
Hartford Schroders Inter...
BIT
F05698
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved